Results 131 to 140 of about 342 (145)

Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents

Dermatology and Therapy, 2022
Christophe Piketty
exaly  

Safety and Efficacy of Nemolizumab for Atopic Dermatitis With Pruritus: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials

Frontiers in Immunology, 2022
Kailibinuer Abulikemu, Fengxia Hu, Maoli Dan   +2 more
exaly  

Anti-Pruritic Effect of Nemolizumab in Hemodialysis Patients With Uremic Pruritus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Study

Clinical and Experimental Nephrology, 2021
Ken Igawa, Hisaki Shimada, Satoshi Funakoshi   +2 more
exaly  

Nemolizumab decreases lesions and itch in prurigo nodularis

Medicom Conference Report AAD 2023, 2023
Shawn Kwatra, Susanne Kammerer
openaire   +1 more source

Nemolizumab gegen Neurodermitis

Aktuelle Dermatologie, 2017
openaire   +1 more source

Nemolizumab‐induced exacerbation of atopic dermatitis

The Journal of Dermatology
Hirofumi Kamada, Nobuyuki Arakawa, Marino Kato, Takayuki Tanji, Daisuke Watabe, Naoki Yanagawa, Hiroo Amano   +6 more
openaire   +2 more sources

A case of bullous pemphigoid after nemolizumab administration

The Journal of Dermatology
Yuriko Ishikawa, Ken Washio
openaire   +2 more sources

Dupilumab/nemolizumab/upadacitinib

Reactions Weekly
openaire   +1 more source

Characteristics of Suitable Cases for Treatment With Nemolizumab Based on Clinical Findings and Cutaneous Adverse Events

Journal of Dermatology
Akiko Sugiyama, Takeshi Nakahara
exaly  

Nemolizumab Improves Pruritus in Patients With Intrinsic Atopic Dermatitis Lacking Atopic Predisposition: A Single-Centre Pilot Retrospective Cohort Study

Experimental Dermatology
Keita Tsutsui, Shinichi Imafuku, Emi Sato   +2 more
exaly